NCT02197455View on ClinicalTrials.gov

Tofacitnib for the Treatment of Alopecia Areata and Variants

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Alopecia Areata (AA)Alopecia Totalis (AT)Alopecia Universalis (AU)
Interventions
DRUG

Tofacitinib Administration

5 mg of Tofacitinib will be taken by mouth twice daily for 3 months.

Trial Locations (1)

Unknown

Yale University, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT02197455 - Tofacitnib for the Treatment of Alopecia Areata and Variants | Biotech Hunter | Biotech Hunter